InsiderTrades.com logo
625,000% Gain
From Crypto Swap Profits   |   Ad
Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.
>> Dive into the Workshop Here

MAP Insider Trading

Insider Ownership Percentage: 54.46%
Insider Buying (Last 12 Months): A$0.00
Insider Selling (Last 12 Months): A$0.00

Microba Life Sciences Insider Trading History Chart

This chart shows the insider buying and selling history at Microba Life Sciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Microba Life Sciences Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 11/9/2022 10:39 AM ET

This chart shows the closing price history over time for MAP up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
War on Elon Escalates…
From Porter & Company   |   Ad
A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.
One company holds a near-total monopoly on it.

Microba Life Sciences Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/7/2022Pasquale (Paddy) RombolaInsiderBuy100,000A$0.18A$18,100.00
See Full Table
Election warning coming true…
From Porter & Company   |   Ad
If you missed it, my emergency election broadcast is now available - watch it before it's too late.
Click here to watch it now.

SEC Filings (Institutional Ownership Changes) for Microba Life Sciences (ASX:MAP)

22.83% of Microba Life Sciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Microba Life Sciences Limited provides microbiome testing and analysis services for clinicians, consumers, and research customers in Australia, Europe, New Zealand, the United Arab Emirates, the United Kingdom, the United States, and Singapore. The company operates through two segments, Testing Services, and Research and Development. It offers pathology, therapeutics, and diagnostics services based on the human gut microbiome; testing and data analysis services for personal and research testing; and data-driven therapeutics platform that develops novel monoclonal microbial cell therapies for inflammatory bowel disease, cancer immunotherapy, and autoimmune diseases, as well as Databank for health and biome data. The company was incorporated in 2017 and is based in Brisbane, Australia.
Read More on Microba Life Sciences

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

N/A

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.81

Who are the company insiders with the largest holdings of Microba Life Sciences?

Microba Life Sciences' top insider shareholders include:
  1. Pasquale (Paddy) Rombola (Insider)
Learn More about top insider investors at Microba Life Sciences.
625,000% Gain
From Crypto Swap Profits   |   Ad
Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.
>> Dive into the Workshop Here